Tags Sino Biopharmaceutical

Tag: Sino Biopharmaceutical

Sino Biopharmaceutical Announces 2020 First Quarterly Results

Revenue was approximately RMB6.22 Billion; Profit Attributable to Owners of the Parent was approximately RMB862 Million Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with...

New Drug Application of Penpulimab Co-developed by Sino Biopharmaceutical and Akeso Accepted by the...

Sino Biopharmaceutical Limited (HKEX: 1177), a leading, innovative R&D driven pharmaceutical conglomerate in the PRC, has announced that the new drug application of the...

Results from Clinical Trials of Penpulimab in Combination with Anlotinib for 1L HCC Co-developed...

Sino Biopharmaceutical Limited (HKEX: 1177), a leading, innovative research and development ("R&D") driven pharmaceutical conglomerate in the PRC, has announced that the abstracts on...

Sino Biopharm Announces 2019 Annual Results

Revenue Climbs 16.0% to RMB24.23 billion Underlying Profit Up 10.2% to RMB3.13 billion; Achieves an outstanding R&D performance and obtains 28 production approvals Sino Biopharmaceutical Limited...

Sino Biopharmaceutical Announces 2018 Third Quarterly Results

Profit Attributable to the Group Increased by Approximately 29.9% to Approximately RMB 2,247,477,000 HONG KONG - (ACN Newswire) - Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the...